Medtronic shares rise 5% on Q1 beat and raised FY27 guidance
- Medtronic Q1 EPS of $1.45 beat the $1.39 estimate
- Quarterly sales of $9.756 billion exceeded the $9.545 billion forecast
- Company raised FY27 adjusted EPS guidance
- Announced $700 million partnership with Cornerstone Robotics
- Healthcare sector rose 1.7% while broader indices fell
*this image is generated using AI for illustrative purposes only.
Medtronic Plc (NYSE: MDT) shares gained around 5% on Tuesday following better-than-expected first-quarter results and an upward revision to its fiscal year 2027 adjusted earnings per share guidance.
The Dow Jones Industrial Average fell more than 300 points, trading down 0.58% to 52,876.43. The NASDAQ Composite dipped 1.40% to 26,001.27, while the S&P 500 dropped 0.68% to 7,633.51.
Earnings Beat
Medtronic reported quarterly earnings of $1.45 per share, surpassing the analyst consensus estimate of $1.39 per share. Quarterly sales reached $9.756 billion, beating the consensus estimate of $9.545 billion.
| Metric | Actual | Consensus Estimate |
|---|---|---|
| Earnings Per Share | $1.45 | $1.39 |
| Quarterly Sales | $9.756 billion | $9.545 billion |
Strategic Partnership
The company announced a $700 million strategic partnership with Cornerstone Robotics. This deal aims to expand global access to Medtronic’s Sentire Surgical System in select non-U.S. markets.
Sector Performance
Health care shares jumped by 1.7% on Tuesday, outperforming the broader market. In contrast, consumer discretionary stocks fell by 1.7%.
Other Movers
bioAffinity Technologies Inc (NASDAQ: BIAF) shares shot up 66% to $7.59 after advancing the potential application of its CyPath Lung Test. Fly-E Group Inc (NASDAQ: FLYE) surged 45% to $1.99. Wetour Robotics Ltd (NASDAQ: WETO) gained 50% to $8.21 following a development demonstration of Orchestra for robot learning.
On the downside, Alumis Inc (NASDAQ: ALMS) dropped 50% to $10.86 after disclosing topline results from its Envudeucitinib Phase 2b trial. KALA BIO Inc (NASDAQ: KALA) fell 19% to $0.54, while Nocera Inc (NASDAQ: NCRA) declined 21% to $2.23.
Global Markets and Commodities
European shares were lower, with the STOXX 600 slipping 0.5%. Asia Pacific markets also closed lower, with Japan’s Nikkei 225 falling 0.15% and India’s BSE Sensex falling 0.02%.
In commodities, oil traded up 2.9% to $88.20. Gold traded down 2.3% at $4,376.60, silver fell 3.2% to $64.875, and copper dropped 1.6% to $6.5795.
Economic Data
The US Logistics Managers’ Index declined for a second straight month to a reading of 66.6 in August, down from 68.9 in the previous month.
How might Medtronic's $700 million partnership with Cornerstone Robotics impact its competitive positioning against other surgical robotics firms like Intuitive Surgical in non-U.S. markets?
Could the upward revision to Medtronic's FY2027 EPS guidance signal a broader recovery trend in the medical devices sector despite the recent decline in major U.S. indices?
What are the potential long-term implications for Medtronic's R&D strategy as it shifts focus toward expanding global access for the Sentire Surgical System?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
